Trial
NCT02232880
Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
Bristol-Myers Squibb
Condition
Hypertension
Intervention
Abatacept
Why stopped
failure to recruit
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-07